<DOC>
	<DOC>NCT00371111</DOC>
	<brief_summary>Cystoid macular edema (CME) is one of the common causes of vision loss in patients with UveitiS .Triamcinolone has been effectively used in reducing CME and improving the vision. Also there are some documents which recommend Bevacizumab(avastin) could reduce macular edema. This study compare intravitreous injection of triamcinolone and avastin in patients with resistant uveitic cystoid macular edema.</brief_summary>
	<brief_title>To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema</brief_title>
	<detailed_description>This study compare intravitreous injection of triamcinolone and avastin in patients with resistant uveitic cystoid macular edema.</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Uveitic CME Uveitic CME refractory to routine treatment Vision better than 5/200 and worse than 20/50 Mono Ocular patients History of vitrectomy Glaucoma or ocular hypertension History of other retinal disease that can cause macular edema Pregnancy Significant media opacity Vision better than 20/50</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Resistant uveitic cystoid macular edema</keyword>
	<keyword>intravitreal triamcinolone</keyword>
	<keyword>intravitreal bevacizumab</keyword>
</DOC>